Analyst firms · Raymond James · LEN

Raymond James LEN price target and rating history

Lennar Corporation (LEN) · Consumer Discretionary

Raymond James rates Lennar Corporation (LEN) Underperform with a $150 price target, as of its latest action on Sep 22, 2025. It has published 6 rating actions on LEN since September 2021, including 1 upgrade and 3 downgrades. Across 11 firms with a LEN price target in the last 12 months, the median target is $95.

Current rating
Underperform
Price target
$150
Median target, all firms
$95
Actions on LEN
6

Raymond James price target on LEN

$150$135$12020222023202420252026
Raymond James price target on LEN, each point a stated target, September 2021 to July 2023.

Every Raymond James rating on LEN

How other firms rate LEN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
MeliusSell$72Oct 6, 2026
Morgan StanleyUnderweight$65Oct 1, 2026
Keefe, Bruyette & WoodsUnderperform$86Jun 9, 2026
Seaport Research PartnersSell$74Apr 7, 2026
Truist SecuritiesHold$110Mar 4, 2026
Citizens JMPMkt PerformJan 7, 2026
UBSNeutral$122Jan 6, 2026
RBC Capital MarketsUnderperform$95Dec 18, 2025
Evercore ISIUnderperform$92Dec 18, 2025
BofA SecuritiesUnderperform$95Dec 18, 2025
BarclaysUnderweight$98Dec 8, 2025
BTIGSell$96Dec 2, 2025

Questions about Raymond James and LEN

What is Raymond James's price target for LEN?
Raymond James's latest stated price target for Lennar Corporation (LEN) is $150, from its action on Jul 14, 2023.
What is Raymond James's rating on LEN?
Raymond James rates LEN Underperform, a bearish rating, as of Sep 22, 2025.
When did Raymond James last change its view on LEN?
On Sep 22, 2025, Raymond James downgrades to Underperform from Mkt Perform.
How does Raymond James's LEN target compare with other analysts?
Across 11 firms with a LEN price target in the last 12 months, the median target is $95.

More LEN rating histories

All Raymond James ratingsLEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.